Exablate Model 4000 System
Insightec · Decision date Sep 16, 2026
What did the FDA approve?
The FDA record P150038/S044, dated 2026-09-16, is an approval of a normal 180-day-track supplement without user fee for the Exablate Model 4000 System, a magnetic-resonance-guided focused ultrasound device under product code POH (Neurology), submitted by Insightec. The supplement's stated reason is a location change covering manufacturer, sterilizer, packager or supplier, and its statement concerns a manufacturing site at Molded Rubber and Plastics Corporation, 13161 W. Glendale Avenue, Butler, WI 53007, USA.
That new Wisconsin location is described as an additional manufacturing site for the Exablate 4000 Treatment Kits. The supplement number identifies it as a change to the original P150038 approval rather than an original PMA, and approving a site is not an approval of the whole system or an independent finding of safety or clinical effectiveness; the record supplies no detail on qualification, inspection or validation of the site, the materials handled there, or any clinical or labeling consequences.
Specific information absent from the supplied fields includes what the kits contain, what operations occur at Butler, and whether the existing manufacturing site or sites remain unchanged.
FDA approval order statement
approval for a manufacturing site located at Molded Rubber and Plastics Corporation, 13161 W. Glendale Avenue, Butler, WI 53007, USA. This new site will be an additional manufacturing site for the Exablate 4000 Treatment Kits.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Neurology
- Decision date
- Sep 16, 2026
- FDA change category
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P150038/S044
- Regulatory pathway
- PMA supplement
- Applicant
- Insightec
- Product code
- POH
- Decision code
- APPR
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: MR-guided focused ultrasound system.
For the original device and its historical approval scope, see PMA P150038. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150038 · Original PMA
EXABLATE
P150038/S044 received
Application receipt date recorded by FDA.
P150038/S044 · FDA decision
Normal 180 Day Track No User Fee
Timeline entries are records held by MedtechLedger for P150038. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150038
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Insightec
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 5 Nahum Heth St., Tirat Carmel, 39120
Sources and methodology
- Original FDA record: P150038/S044
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records